Cure Rate Completed Phase 2 Trials for Cipargamin (DB12306)

IndicationStatusPhase
DBCOND0063978 (Cure Rate)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01860989A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infectionTreatment